SUNMARK 12 HOUR ALLERGY RELIEF

Manufacturer
Strategic Sourcing Services LLC
Effective date
2019-08-27
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 00:13:59

Label at a glance#

ProductSUNMARK 12 HOUR ALLERGY RELIEF
Active ingredientCLEMASTINE FUMARATE
Label structure9 sections

Indications and uses

temporarily reduces these symptoms of the common cold, hay fever, and other respiratory allergies: • runny nose • itchy, watery eyes • sneezing • itching of the nose or throat

Dosage and administration

• adults and children 12 years of age and over: take 1 tablet every 12 hours; not more than 2 tablets in 24 hours unless directed by a doctor • children under 12 years of age: consult a doctor

Storage and handling

• sodium free • store at 15°-30°C (59°-86°F)

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Clemastine fumarate, USP 1.34 mg (equivalent to 1 mg clemastine)

Purpose

OTC - PURPOSE SECTION

Antihistamine

Uses

INDICATIONS & USAGE SECTION

temporarily reduces these symptoms of the common cold, hay fever, and other respiratory allergies:

  1. runny nose
  2. itchy, watery eyes
  3. sneezing
  4. itching of the nose or throat

Warnings

WARNINGS SECTION

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  1. a breathing problem such as emphysema or chronic bronchitis
  2. glaucoma
  3. trouble urinating due to an enlargement of the prostate gland

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

taking sedatives or tranquilizers

When using this product

OTC - WHEN USING SECTION

  1. avoid alcoholic drinks
  2. drowsiness may occur
  3. alcohol, sedatives, and tranquilizers may increase drowsiness
  4. be careful when driving a motor vehicle or operating machinery
  5. excitability may occur, especially in children

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  1. adults and children 12 years of age and over: take 1 tablet every 12 hours; not more than 2 tablets in 24 hours unless directed by a doctor
  2. children under 12 years of age: consult a doctor

Other information

STORAGE AND HANDLING SECTION

  1. sodium free
  2. store at 15°-30°C (59°-86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, lactose monohydrate, povidone, pregelatinized starch, starch, stearic acid

Questions or comments?

OTC - QUESTIONS SECTION

1-800-719-9260

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Compare to Tavist® Allergy active ingredient

12 Hour Allergy Relief

Clemastine Fumarate Tablets, USP 1.34 mg

Antihistamine

Relieves: Runny Nose, Sneezing

Itchy, Watery Eyes, Itchy Throat

Allergy

12 Hour Allergy Relief Carton
12 Hour Allergy Relief Carton

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
49348-686-03EA - Each49348-68695448467-a08d-4ef1-baff-35c948fe5bc712012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CLEMASTINE FUMARATEACTIVE INGREDIENT19259EGQ3D1
CLEMASTINEACTIVE MOIETY95QN29S1ID1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49348-68649348-686-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A074512-001CLEMASTINE FUMARATECLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-2284e616aacf4f…
2026-08-18 06:07:402026-07A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-226a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-2203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-222680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-225bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-2279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-221e350fbaab3a…
2024-05-31 18:47 UTC2024-05A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-228072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-225c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-225d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-224b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-2274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-22bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-22782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-2287673890dc5c…
2021-03-12 10:30 UTC2021-03A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-225aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-228869cabd3fbd…
2020-11-12 02:37 UTC2020-11A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-22c0c555d07b60…
2019-12-14 00:12 UTC2019-12A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-223f01610625f2…
2019-09-15 20:21 UTC2019-09A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-22b00525d2431f…
2019-07-19 19:46 UTC2019-07A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORALRS1995-11-22ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-226a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-221c564ffb4f44…
2023-12-20 04:57 UTC2023-12A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-229b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-223f0d92c62455…
2023-05-13 08:27 UTC2023-05A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22053a50430f4f…
2023-01-26 05:58 UTC2023-01A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-223bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-223a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A074512-001CLEMASTINE FUMARATE1.34MGTABLET / ORAL1995-11-22f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
34f0d1ac-a5ba-4028-b6ff-7c02f96a3e0a539e2c02-b258-45ea-8694-58ce5165ea7c2021-05-13WarningsExact identifier
spl set id: 539e2c02-b258-45ea-8694-58ce5165ea7c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.